Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00095680. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00618345. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma
ClinicalTrials.gov study NCT04212858. IPD Sharing: NO. Countries: 0. Publications: 0.
Clinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Third-line or Above Treatment
ClinicalTrials.gov study NCT07195617. IPD Sharing: YES. Countries: 0. Publications: 0.
Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma
ClinicalTrials.gov study NCT05346835. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase I Clinical Study of CBG002 CAR-T Cell in Treatment of Relapsed/refractory Multiple Myeloma
ClinicalTrials.gov study NCT06705725. IPD Sharing: NO. Countries: 0. Publications: 0.
Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02082405. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Pilot Study of an Oral Chemotherapy Teaching Tool to Improve Adherence in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT04376957. IPD Sharing: NO. Countries: 0. Publications: 0.
Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT03283046. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.
ClinicalTrials.gov study NCT01268774. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01680796. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Comparison of the Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Between in HEPA-filtered Room and Non-HEPA-filtered Room
ClinicalTrials.gov study NCT06286241. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
A Single-arm Single-center Trial of Bridging GPRC5D/CD3 Bispecific Antibody Treatment With BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07185477. IPD Sharing: NO. Countries: 0. Publications: 0.
A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a N
ClinicalTrials.gov study NCT05545202. IPD Sharing: Not stated. Countries: 0. Publications: 0.
LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06888752. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients
ClinicalTrials.gov study NCT00561743. IPD Sharing: Not stated. Countries: 0. Publications: 0.
CAR-T Cell Efficacy With Molecular Imaging in Multiple Myeloma
ClinicalTrials.gov study NCT07280793. IPD Sharing: NO. Countries: 0. Publications: 0.
Prevalence of Ocular Disorders in Multiple Myeloma (MM-OO-16)
ClinicalTrials.gov study NCT02917239. IPD Sharing: NO. Countries: 0. Publications: 0.
An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
ClinicalTrials.gov study NCT06655519. IPD Sharing: NO. Countries: 0. Publications: 0.
BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma
ClinicalTrials.gov study NCT07196124. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.